UBS Group AG - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 32 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q4 2019$10,000
+42.9%
44,664
+231.1%
0.00%
Q3 2019$7,00013,488
+23563.2%
0.00%
Q2 2019$0
-100.0%
57
-98.8%
0.00%
Q1 2019$7,0004,671
+5812.7%
0.00%
Q4 2018$0
-100.0%
79
-99.1%
0.00%
Q3 2018$18,000
+500.0%
8,824
+386.7%
0.00%
Q2 2018$3,0001,8130.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2018
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 1,125,000$253,0000.23%
IMS Capital Management 23,472$5,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 181$00.00%
UBS Group AG 44,664$10,0000.00%
IFP Advisors, Inc 0$00.00%
BNP PARIBAS FINANCIAL MARKETS 2$00.00%
Advisor Group, Inc. 785$00.00%
Jacobi Capital Management LLC 20$00.00%
BANK OF AMERICA CORP /DE/ 65$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 3$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders